28113047|t|Temporal upregulation of host surface receptors provides a window of opportunity for bacterial adhesion and disease
28113047|a|Host surface receptors provide bacteria with a foothold from which to attach, colonize and, in some cases, invade tissue and elicit human disease. In this review, we discuss several key host receptors and cognate adhesins that function in bacterial pathogenesis. In particular, we examine the elevated expression of host surface receptors such as CEACAM-1, CEACAM-6, ICAM-1 and PAFR in response to specific stimuli. We explore how upregulated receptors, in turn, expose the host to a range of bacterial infections in the respiratory tract. It is apparent that exploitation of receptor induction for bacterial adherence is not unique to one body system, but is also observed in the central nervous, gastrointestinal and urogenital systems. Prokaryotic pathogens which utilize this mechanism for their infectivity include Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis and Escherichia coli. A number of approaches have been used, in both in vitro and in vivo experimental models, to inhibit bacterial attachment to temporally expressed host receptors. Some of these novel strategies may advance future targeted interventions for the prevention and treatment of bacterial disease.
28113047	9	21	upregulation	T044	C0041904
28113047	25	47	host surface receptors	T116,T192	C0034800
28113047	85	103	bacterial adhesion	T040	C0004614
28113047	108	115	disease	T047	C0004623
28113047	116	138	Host surface receptors	T116,T192	C0034800
28113047	147	155	bacteria	T007	C0004611
28113047	186	192	attach	T067	C3714578
28113047	230	236	tissue	T024	C0040300
28113047	248	253	human	T016	C0086418
28113047	254	261	disease	T047	C0012634
28113047	302	316	host receptors	T116,T192	C0034800
28113047	321	337	cognate adhesins	T026	C0699040
28113047	355	364	bacterial	T007	C0004611
28113047	365	377	pathogenesis	T046	C0699748
28113047	409	417	elevated	T080	C3163633
28113047	418	428	expression	T045	C0597360
28113047	432	454	host surface receptors	T116,T192	C0034800
28113047	463	471	CEACAM-1	T116,T129	C3540477
28113047	473	481	CEACAM-6	T116,T129	C0376900
28113047	483	489	ICAM-1	T116,T129	C0063695
28113047	494	498	PAFR	T116,T129,T192	C0071234
28113047	502	530	response to specific stimuli	T039	C0542478
28113047	547	568	upregulated receptors	T044	C0949479
28113047	590	594	host	T001	C1167395
28113047	609	629	bacterial infections	T047	C0004623
28113047	637	654	respiratory tract	T022	C0035237
28113047	692	700	receptor	T116,T192	C0597357
28113047	701	710	induction	T169	C0205263
28113047	715	734	bacterial adherence	T040	C0004614
28113047	756	767	body system	T022	C0460002
28113047	797	812	central nervous	T022	C3714787
28113047	814	830	gastrointestinal	T022	C0012240
28113047	835	853	urogenital systems	T022	C0042066
28113047	855	866	Prokaryotic	T001	C0686817
28113047	867	876	pathogens	T046	C0699748
28113047	916	927	infectivity	T046	C3714514
28113047	936	960	Streptococcus pneumoniae	T007	C0038410
28113047	962	984	Haemophilus influenzae	T007	C0018483
28113047	986	1008	Neisseria meningitidis	T007	C0027575
28113047	1013	1029	Escherichia coli	T007	C0014834
28113047	1078	1086	in vitro	T062	C1515654
28113047	1091	1118	in vivo experimental models	T062	C1515657
28113047	1131	1151	bacterial attachment	T040	C0004614
28113047	1166	1175	expressed	T045	C0597360
28113047	1176	1190	host receptors	T116,T192	C0034800
28113047	1242	1250	targeted	T169	C1521840
28113047	1251	1264	interventions	T058	C1273869
28113047	1273	1283	prevention	T061	C0199176
28113047	1288	1297	treatment	T061	C0087111
28113047	1301	1318	bacterial disease	T047	C0004623